The main aim of this activity is to collect information on the severity of breakthrough COVID-19 infections in outbreaks at long-term care facilities (LTCFs) and to obtain an estimate of relative risk of infection for vaccinated residents and staff members in these settings, by SARS-CoV-2 variant, vaccine product and number of vaccine doses.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 January 2022 and includes updates on COVID-19, the Omicron variant, avian influenza, seasonal influenza, MERS-CoV, meningitis, dengue and chikungunya.
ECDC has worked with EU/EEA countries to develop a methodology for regular national reporting of existing national surveillance data on COVID-19 in LTCFs, aiming for maximum feasibility. This is to enable ECDC to communicate timely information on epidemiological trends of COVID-19 in LTCFs, in support of national and EU/EEA-level preparedness and response activities.
European Antibiotic Awareness Day (EAAD) is a European health initiative coordinated by ECDC. It provides a platform and support for national campaigns on the prudent use of antibiotics in the EU/EEA and is marked each year across Europe on 18 November. Due to the COVID-19 pandemic, EAAD will this year consist of a entirely digital campaign.
This document aims to help public health authorities in EU/EEA countries and the UK in their tracing and
management of persons, including healthcare workers, who have had contact with COVID-19 cases.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5-11 September 2021 and includes updates on COVID-19, West Nile virus, measles, Nipah virus, meningitis, plague and polio.
For 2019, 30 EU/EEA Member States reported 29 996 cases of hepatitis B virus (HBV) infection. Excluding the five countries that only reported acute cases, the number of cases, 29 518, corresponds to a crude rate of 7.4 cases per 100 000 population.